Holgate, S. T.

INFbeta therapy for COVID-19 the new SNG001 drug / [electronic resource] : INFβ therapy for COVID-19 : the new SNG001 drug Interferon-beta therapy for COVID-19 : the new SNG001 drug Stephen Holgate. - London : Henry Stewart Talks, 2020. - 1 online resource (1 streaming audio file (10 min.)). - Interviews on Covid-19, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19. .

Audio interview. Title from title frames.

Contents: Why INFβ was chosen as a therapy for COVID-19 -- Previous use of INFβ by inhalation -- Safety of INFβ as a therapy -- SNG001 mode of delivery -- SNG001 clinical trials and future prospects.

Access restricted to subscribers.


Mode of access: World Wide Web.

8172 Henry Stewart Talks


Antiviral agents--Development.
Clinical trials.
Coronavirus infections--Chemotherapy.
COVID-19 (Disease)--Treatment.
Interferon.
Antiviral Agents--administration & dosage.
Clinical Trials as Topic.
Coronavirus infections.
COVID-19--drug therapy.
Drug Delivery Systems.
Interferon-beta--administration & dosage.
Interferon-beta--therapeutic use.
Nebulizers and Vaporizers.
SARS-CoV-2.
Treatment Outcome.
Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571